Suchergebnisse - "Sato, Shuntaro"

PubPharm (218)

21

Response to a letter to the editor by Aoki et al. : Critical considerations, including overfitting in regression models and confounding in study designs for delirium follow-up

enthalten in: Journal of anesthesia | 2023

von Kaneko, S. | Sato, S. | Morimoto, T. | +4

CommentOn: J Anesth. 2023 Apr;37(2):210-218. - PMID 36463532

22

Impacts of trans-anal tube placement in patients with sigmoid colon cancer : Risk verification analysis using inverse probability weighting analysis

enthalten in: Annals of gastroenterological surgery | 2023

von Tominaga, T. | Nonaka, T. | Shiraishi, T. | +7

23

Balance of the prooxidant and antioxidant system is associated with mortality in critically ill patients

enthalten in: Journal of clinical biochemistry and nutrition | 2023

von Izumino, H. | Tajima, G. | Tasaki, O. | +8

24

Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate : comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: Trials | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

25

Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: Trials | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

26

Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial

enthalten in: Trials | 2023

von Shimizu, T. | Kawashiri, S. | Morimoto, S. | +8

27

Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure : Rationale for and design of the EMPA-AHF trial

enthalten in: American heart journal | 2023

von Horiuchi, Y. | Matsue, Y. | Nogi, K. | +10

28

Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort study

enthalten in: Frontiers in immunology | 2023

von Uchida, T. | Ichinose, K. | Yamashita, A. | +6

29

Impacts of trans‐anal tube placement in patients with sigmoid colon cancer : Risk verification analysis using inverse probability weighting analysis

enthalten in: Annals of Gastroenterological Surgery | 2023

von Tominaga, T. | Nonaka, T. | Shiraishi, T. | +7

30

Association between hospital acquired disability and post-discharge mortality in patients after living donor liver transplantation

enthalten in: BMC surgery | 2022

von Hanada, M. | Hidaka, M. | Soyama, A. | +13